John Howard Sampson

USPTO Granted Patents = 25 (Patent Applications = 11)

CIPO Patents = 5

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 3.1

ph-index = 6

Forward Citations = 97(Granted Patents)

Company Filing History:

The United States of America, As Represented by the Secretary, Department of Health and Human Services

University of Texas System

patents

5. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2024

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12070496 - Compositions, methods and kits for eliciting an immune response (2024-08-27),

2. 11813298 - Oncolytic poliovirus for human tumors (2023-11-14),

3. 11684662 - Tetanus toxoid and CCL3 improve DC vaccines (2023-06-27),

4. 11406677 - Oncolytic poliovirus for human tumors (2022-08-09),

5. 11389530 - Compositions, methods and kits for eliciting an immune response (2022-07-19),

6. 11376322 - Compositions, methods and kits for eliciting an immune response (2022-07-05),

7. 11364295 - Compositions, methods and kits for eliciting an immune response (2022-06-21),

8. 11351248 - Compositions, methods and kits for eliciting an immune response (2022-06-07),

9. 11071777 - Tetanus toxoid and CCL3 improve DC vaccines (2021-07-27),

10. 10799543 - Oncolytic poliovirus for human tumors (2020-10-13),

11. 10744171 - Sequential anti-cancer treatment (2020-08-18),

12. 10632190 - Compositions, methods and kits for eliciting an immune response (2020-04-28),

13. 10398743 - Oncolytic poliovirus for human tumors (2019-09-03),

14. 10053514 - Human bispecific EGFRvIII and CD3 antibody engaging molecules (2018-08-21),

15. 9974848 - Tetanus toxoid and CCL3 improve DC vaccines (2018-05-22),

Title: John Howard Sampson: Innovator in Cancer Treatment

Introduction

John Howard Sampson is a distinguished inventor based in Durham, NC, with an impressive portfolio of 25 patents. His work primarily focuses on innovative approaches to eliciting immune responses and advancing cancer treatments, significantly contributing to the field of medical research.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions, methods and kits for eliciting an immune response." This invention relates to the development of compositions and kits designed to provoke an immune response specifically to at least one cytomegalovirus (CMV) antigen expressed by cancer cells. The goal is to improve strategies for treating and preventing cancer. Additionally, Sampson has patented "Oncolytic poliovirus for human tumors," which describes a chimeric poliovirus construct demonstrating remarkable anti-tumor effects in human clinical applications. This invention operates through mechanisms involving viral oncolysis and immune recruitment, ultimately leading to necrosis of the tumor without adverse effects.

Career Highlights

Sampson's career has been marked by significant associations with reputable organizations, including Duke University, where he carried out extensive research and development in the medical field. He has also held the position of Secretary at the Department of Health and Human Services (DHHS), contributing his expertise to public health initiatives.

Collaborations

Throughout his illustrious career, John Howard Sampson has collaborated with esteemed colleagues, such as Duane A. Mitchell and Darell D. Bigner. These partnerships have enriched his research endeavors and furthered innovation in cancer treatment.

Conclusion

John Howard Sampson's contributions to cancer immunotherapy through his inventions and patents have the potential to revolutionize treatment methodologies. His dedication to advancing medical science is evident through his collaborative efforts and innovative spirit, positioning him as a pivotal figure in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.